Live Breaking News & Updates on Seika

Stay informed with the latest breaking news from Seika on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Seika and stay connected to the pulse of your community

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) -April 08, 2024 at 01:02 am EDT

EQS-News: Newron Pharmaceuticals S.p.A.

/ Key word: Study results

Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual...

Israel , Australia , Canada , Bresso , Lombardia , Italy , Germany , Milan , Switzerland , Seika , Kyongsang-bukto , South-korea

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) -April 08, 2024 at 07:06 am EDT

Data from study 014/015, a phase II trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia for up to one year

Presentation of study design for potentially...

United-kingdom , Seika , Kyongsang-bukto , South-korea , India , Sri-lanka , Switzerland , Japan , United-arab-emirates , Milan , Lombardia , Italy

Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS) | Region

MILAN--(BUSINESS WIRE)--Apr 8, 2024--

Canada , Milan , Lombardia , Italy , Switzerland , Seika , Kyongsang-bukto , South-korea , India , United-kingdom , Sri-lanka , United-states

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

EQS-News: Newron Pharmaceuticals S.p.A.

/ Key word: Study results

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia...

United-kingdom , United-arab-emirates , Italy , Bresso , Lombardia , Seika , Kyongsang-bukto , South-korea , United-states , Japan , Switzerland , Canada

EQS-News: Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

EQS-News: Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Canada , Seika , Kyongsang-bukto , South-korea , Australia , Hempstead , Gloucestershire , United-kingdom , Japan , Switzerland , Milan , Lombardia

Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide in Treatment-resistant Schizophrenia (TRS)

Ad hoc announcement pursuant to Art. 53 LR

Treatment with evenamide demonstrated significant, clinically important, progressive, sustained and long-lasting improvement on PANSS total, CGI-S and...

Bresso , Lombardia , Italy , India , South-korea , Germany , Sri-lanka , Switzerland , Australia , Seika , Kyongsang-bukto , United-arab-emirates

Newron Pharmaceuticals S.p.A.: Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide in Treatment-resistant Schizophrenia (TRS)

Newron Pharmaceuticals S.p.A.: Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide in Treatment-resistant Schizophrenia (TRS)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Seika , Kyongsang-bukto , South-korea , United-arab-emirates , United-states , Australia , Germany , Switzerland , Sri-lanka , Italy , India , Bresso

EQS-News: Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide

EQS-News: Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Germany , South-korea , Bresso , Lombardia , Italy , Switzerland , Australia , United-arab-emirates , United-states , Milan , Seika , Kyongsang-bukto

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenam

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): StudyNewron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide 29.12.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Newron completes enrollment of schizophrenia patie...

United-arab-emirates , Seika , Kyongsang-bukto , South-korea , Germany , Bresso , Lombardia , Italy , United-states , United-kingdom , Japan , Israel

Newron Pharmaceuticals S.p.A.: Newron Completes Enrollment of Schizophrenia Patients in Potentially Pivotal Study 008A With Evenamide

Newron Pharmaceuticals S.p.A.: Newron Completes Enrollment of Schizophrenia Patients in Potentially Pivotal Study 008A With Evenamide
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Seika , Kyongsang-bukto , South-korea , Germany , Milan , Lombardia , Italy , Japan , Bresso , Switzerland , United-kingdom , Australia